P. Williams

发表

Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors

C. Lewis, J. Harmey, S. Tazzyman, 2009, Gene Therapy.

The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

Paul J. Williams, T. Yoneda, G. Mundy, 2001, Cancer research.

Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells.

K. Rabe, Steven Sun, D. Dorscheid, 2001, American journal of respiratory cell and molecular biology.

Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

T. Yoneda, G. Mundy, T. Michigami, 2000, Blood.

Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin‐6 in nude mice

Paul J. Williams, T. Yoneda, K. Moriyama, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Androgens Rapidly Activate Nuclear Factor-Kappa B via Intracellular Ca2+ Signalling in Human Vascular Endothelial Cells

K. Gaus, D. Celermajer, P. Williams, 2012 .

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Paul J. Williams, T. Yoneda, T. Michigami, 1999, Cancer treatment reviews.

Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.

Paul J. Williams, T. Yoneda, G. Mundy, 2001, Cancer research.

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Paul J. Williams, F. Bauss, T. Yoneda, 1997, The Journal of clinical investigation.

E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

T. Yoneda, G. Mundy, A. Sasaki, 1996, Cancer research.

A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice.

T. Yoneda, G. Mundy, B. Boyce, 1992, Cancer research.

539 Comparative pharmacokinetic (PK) study of a cremophor-free, protein stabilized, nanoparticle formulation (ABI-007) and a cremophor-based formulation of paclitaxel (P) in patients with advanced solid tumors

L. Harris, P. Soon-Shiong, N. Desai, 2004 .

Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.

T. Yoneda, G. Mundy, B. Boyce, 1995, Cancer research.

Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.

T. Yoneda, Y. Uehara, G. Mundy, 1993, The Journal of clinical investigation.

Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.

Paul J. Williams, W. Ma, J. Wang, 2004, Anticancer research.

15a-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models

P. Yue, J. Turkson, P. Williams, 2017 .